Clinical study of the effect of combined treatment of aspirin and zileuton on biomarkers of tobacco-related carcinogenesis in current smokers
Ended Awarded Last action
- Contract number
- HHSN26100005
- Awardee
-
University Of Arizona UEI ED44Y3W6P7B9 Part of State Of Arizona
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,476,557
Award facts
- Opportunity
-
- N01CN0501469 Solicitation number
- Contract value 100% obligated
- $1,476,557.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Tucson, AZ 85719, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $0 | |
| Exercise an Option | $102,639 | |
| Supplemental Agreement for work within scope | $329,242 | |
| Funding Only Action | $165,927 | |
| Original award | $878,749 |
About this award
This is a federal contract award from the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Arizona, a public research university and land grant institution, for a clinical study on the effects of combined aspirin and zileuton treatment on tobacco-related carcinogenesis biomarkers in current smokers. The $1,476,557 award falls under the Cancer Prevention Agent Development Program 2012-2017 indefinite delivery vehicle, and has a period of performance ending on December 31, 2021. The contract does not have a set-aside designation. As a major research university, the University of Arizona has extensive capabilities across numerous scientific and technical disciplines, and has been awarded both prime contracts and subcontracts by various federal agencies, including NASA, NIH, USDA, and DARPA, in addition to grant funding.
Quick answers
Who was awarded contract HHSN26100005?
HHSN26100005 was awarded to University Of Arizona by National Cancer Institute (National Institutes of Health) on September 1, 2014.
How much is contract HHSN26100005 worth?
The government has obligated $1,476,557 on HHSN26100005.
Is contract HHSN26100005 an order under another contract?
Yes. HHSN26100005 is a delivery order under HHSN261201200031I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.
Was contract HHSN26100005 competed?
The extent of competition for HHSN26100005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award